Patents by Inventor Brij Khera

Brij Khera has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pitavastatin calcium and process for its preparation
    Patent number: 9034901
    Abstract: The invention provides the process for the preparation of pitavastatin and its pharmaceutically acceptable salts thereof. In particular, the invention provides a process for the preparation of stable pitavastatin calcium in crystalline form having water content less than 5% wt/wt. The present invention also provides stable crystalline form of pitavastatin calcium substantially free from crystal Form-A and use thereof for pharmaceutical compositions.
    Type: Grant
    Filed: August 24, 2011
    Date of Patent: May 19, 2015
    Assignee: Cadila Healthcare Limited
    Inventors: Shriprakash Dhar Dwivedi, Dhimant Jasubhai Patel, Alpesh Pravinchandra Shah, Brij Khera
  • Delayed Release Pharmaceutical Compositions of Salsalate
    Publication number: 20150037408
    Abstract: The present invention relates to modified release pharmaceutical compositions comprising salsalate. The invention also relates to processes for the preparation of such compositions.
    Type: Application
    Filed: October 21, 2014
    Publication date: February 5, 2015
    Inventors: Kothari Jay Shantilal, Muthaiyyan Esakkimuthu Kannan, Mistry Gaurav Navinbhai, Brij Khera
  • PHARMACEUTICAL COMPOSITIONS OF LURASIDONE
    Publication number: 20140348909
    Abstract: The present invention relates to pharmaceutical compositions of lurasidone or salts thereof. In particular, the invention relates to pharmaceutical compositions of lurasidone or salts thereof with one or more water-insoluble pharmaceutical excipients. The invention also relates to processes for the preparation of such compositions and use thereof for treatment of schizophrenia, bipolar disorders or senile dementia.
    Type: Application
    Filed: January 5, 2012
    Publication date: November 27, 2014
    Applicant: Cadila Healthcare limited
    Inventors: Brij Khera, Aman Trehan, Pankaj Ramanbhai Patel
  • Method for preparation of pitavastatin and pharmaceutical acceptable salts thereof
    Patent number: 8829186
    Abstract: The present invention discloses a compound, which is alkali or alkaline earth metal salts of pitavastatin, wherein the alkali or earth metal comprise one or more of magnesium, zinc, potassium, strontium and barium.
    Type: Grant
    Filed: November 1, 2012
    Date of Patent: September 9, 2014
    Assignee: Cadila Healthcare Limited
    Inventors: Shriprakash Dhar Dwivedi, Dhimant Jasubhai Patel, Alpesh Pravinchandra Shah, Brij Khera
  • PITAVASTATIN CALCIUM AND PROCESS FOR ITS PREPARATION
    Publication number: 20140148481
    Abstract: The invention provides the process for the preparation of pitavastatin and its pharmaceutically acceptable salts thereof. In particular, the invention provides a process for the preparation of stable pitavastatin calcium in crystalline form having water content less than 5% wt/wt. The present invention also provides stable crystalline form of pitavastatin calcium substantially free from crystal Form-A and use thereof for pharmaceutical compositions.
    Type: Application
    Filed: August 24, 2011
    Publication date: May 29, 2014
    Applicant: CADILA HEALTHCARE LIMITED
    Inventors: Shriprakash Dhar Dwivedi, Dhimant Jasubhai Patel, Alpesh Pravinchandra Shah, Brij Khera
  • Novel amorphous form of sertraline hydrochloride
    Publication number: 20040063792
    Abstract: This invention relates to a novel amorphous form of sertraline hydrochloride and a process for the preparation thereof.
    Type: Application
    Filed: June 4, 2003
    Publication date: April 1, 2004
    Inventors: Brij Khera, Amit Rohatgi, Om Dutt Tyagi, Yatendra Kumar
  • Process for the preparation of 1,8-disubstituted-1,3,4,9-tetrahydropyrano (3,4-B)-indole-1-acetic acid esters
    Patent number: 6331638
    Abstract: A process for the preparation of the esters of 1,8-disubstituted-1,3,4,9-tetrahydropyrano (3,4-b)-indole-1-acetic acid is delineated.
    Type: Grant
    Filed: October 4, 1999
    Date of Patent: December 18, 2001
    Assignee: Ranbaxy Laboratories Limited
    Inventors: B. Vijay Raghavan, K. V. Ramana, Brij Khera, Naresh Kumar
  • Process for the manufacture of pharmaceutical grade ranitidine base
    Patent number: 5696275
    Abstract: A process for the manufacture of pharmaceutical grade ranitidine base(N-?2-???5-(Dimethylamino)methyl!-2-furanyl!methyl!thio!ethyl-N'-methy l-2-nitro-1, 1-ethenediamine), is described. In-vitro and in-vivo pharmacological studies and acute toxicity studies indicate that it is as active and as safe as Form 2 ranitidine hydrochloride.
    Type: Grant
    Filed: June 24, 1994
    Date of Patent: December 9, 1997
    Assignee: Ranbaxy Laboratories Limited
    Inventors: Jag Mohan Khanna, Naresh Kumar, Brij Khera, Purna Chandra Ray
  • Process for the manufacture of form 1 ranitidine hydrochloride
    Patent number: 5621120
    Abstract: A process for the manufacture of Form 1 ranitidine hydrochloride (N-[2-[[[5-(Dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl-N'-methyl-2- nitro-1,1-ethenediamine) hydrochloride, is described. A process to convert ranitidine hydrochloride Form 2 to Form 1 is also described.
    Type: Grant
    Filed: June 24, 1994
    Date of Patent: April 15, 1997
    Assignee: Ranbaxy Laboratories Limited
    Inventors: Jag M. Khanna, Naresh Kumar, Brij Khera, Mahavir S. Khanna